Profesor del Departamento de Ingeniería Química y Tecnología Farmacéutica, Facultad de Farmacia. Universidad de La Laguna Universidad de La Laguna España.
Publications dans "Assurance prestations pharmaceutiques" :
The University of Sydney School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Australia. Electronic address: vivien.tong@sydney.edu.au.
Publications dans "Assurance prestations pharmaceutiques" :
The University of Sydney School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Australia. Electronic address: ines.krass@sydney.edu.au.
Publications dans "Assurance prestations pharmaceutiques" :
The University of Sydney School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Australia. Electronic address: parisa.aslani@sydney.edu.au.
Publications dans "Assurance prestations pharmaceutiques" :
Faculty of Pharmacy, Federal University of Minas Gerais, Av. Presidente Antônio Carlos, 6627, Pampulha, Belo Horizonte, Minas Gerais, 31.270-901, Brazil.
Publications dans "Assurance prestations pharmaceutiques" :
Departamento de Política de Medicamentos e Assistência Farmacêutica, Escola Nacional de Saúde Pública Sergio Arouca, Fundação Oswaldo Cruz. R. Leopoldo Bulhões 1480, Manguinhos. 21041-210 Rio de Janeiro RJ Brasil. claudiaosorio.soc@gmail.com.
Publications dans "Assurance prestations pharmaceutiques" :
Division of Services and Intervention Research; National Institute of Mental Health; 6001 Executive Boulevard, Bethesda, MD 20892, USA, michael.freed@nih.gov.
Publications dans "Assurance prestations pharmaceutiques" :
The Department of Management and Health Economics, School of Public Health, Hebrew University of Jerusalem, Jerusalem, Israel. shuli.brammli@mail.huji.ac.il.
Myers-JDC Brookdale institute, Jerusalem, Israel. shuli.brammli@mail.huji.ac.il.
Publications dans "Assurance prestations pharmaceutiques" :
Drug insurance schemes are systems that provide access to medicines on a prepaid basis and could potentially improve access to essential medicines and reduce out-of-pocket payments for vulnerable popu...
To assess the effects on drug use, drug expenditure, healthcare utilisation and healthcare outcomes of alternative policies for regulating drug insurance schemes....
We searched CENTRAL, MEDLINE, Embase, nine other databases, and two trials registers between November 2014 and September 2020, including a citation search for included studies on 15 September 2021 usi...
We planned to include randomised trials, non-randomised trials, interrupted time-series studies (including controlled ITS [CITS] and repeated measures [RM] studies), and controlled before-after (CBA) ...
Two review authors independently extracted data from the included studies and assessed risk of bias for each study, with disagreements being resolved by consensus. We used the criteria suggested by Co...
We identified 58 studies that met the inclusion criteria (25 interrupted time-series studies and 33 controlled before-after studies). Most of the studies (54) assessed a single policy implemented in t...
The introduction of drug insurance schemes such as Medicare Part D in the US health system may increase prescription drug use and may decrease out-of-pocket payments by the beneficiaries of the scheme...
Increasing spending and use of prescription drugs pose an important challenge to governments that seek to expand health insurance coverage to improve population health while controlling public expendi...
We conducted a systematic umbrella review with a quality assessment of included studies to examine the association of prescription drug insurance and cost-sharing with drug use, health services use, a...
We identified 38 reviews. We found consistent evidence that having drug insurance and lower cost-sharing among the insured were associated with increased drug use while the lack or loss of drug insura...
Given that the poor or near-poor often report substantially lower drug insurance coverage, universal pharmacare would likely increase drug use among lower-income populations relative to higher-income ...
In Canada, public insurance for physician and hospital services, without cost-sharing, is provided to all residents. Outpatient prescription drug coverage, however, is provided through a patchwork sys...
We conducted a systematic review to examine the association of drug insurance and cost-sharing with drug use, health services use, and health in Canada. We searched 4 electronic databases, 2 grey lite...
The expansion of drug insurance was associated with increases in drug use, individuals who reported drug insurance generally reported higher drug use, and increases in and higher levels of drug cost-s...
Increased cost-sharing is likely to reduce drug use. Universal pharmacare without cost-sharing may reduce inequities because it would likely increase drug use among lower-income populations relative t...
To describe the extent to which New Brunswick residents reported having drug insurance coverage supplementary to Canadian Medicare; to examine associations between socioeconomic and demographic charac...
We used repeated cross-sectional data for New Brunswick from eight cycles of the Canadian Community Health Survey from 2007 to 2017 and undertook logistic regression analysis....
We found statistically significant, substantial and policy-relevant socioeconomic differences in the reporting of prescription drug insurance coverage among those 25-64 years and those ≥ 65 years of a...
Our findings emphasize the shortcomings of drug insurance systems such as that introduced in New Brunswick and substantiate calls for a universal drug program. New Brunswick's increasing reliance on p...
This paper investigates the effects of a mandatory, universal prescription drug insurance policy on health behaviors and outcomes within a public health care system providing physician and hospital se...
Unlike some other high-income counties, Canada does not provide universal prescription drug coverage. The various extent of coverage may left some Canadians vulnerable to cost-related non-adherence (C...
Studies have shown that reducing out-of-pocket costs can lead to higher medication initiation rates in childhood. Whether the cost of such initiatives is inflated by moral hazard issues remains a ques...
A 62-year-old patient, dependent, with good therapeutic adherence and the presence of psychiatric illnesses that limit his quality of life. Your soon, a caregiver since his personality disorder was di...
He was referred to his primary care physician with a multidisciplinary consultation report indicating possible NOM and possible modifications....
The primary care physician accepted the intervention and began with a progressive deprescription of benzodiazepines, with respect to the extrapyramidal symptoms, the NOM was confirmed, and he was refe...
The coordination of the different health professionals allows an increase in the autonomy of the patient, a deprescription of medications and an optimization of health resources, translating into an i...
A 73-year-old woman, independent, with a medical history of psychopathology under treatment and non-compliant. After a fall, he suffered a forearm fracture and, in this context, abuse of psychoactive ...
The state of the patient's situation was evaluated, and an abuse of the hypnotic-anxiolytic treatment was observed, which could be related to her recent forearm fracture. His poor therapeutic adherenc...
He was referred to his primary care physician with a pharmacist consultation report, indicating the possible NMRs and therapeutic alternatives in antihypertensive and antidepressant treatment....
The family physician related the fall and subsequent forearm fracture, as well as the decompensation of his basal pathology, with therapeutic noncompliance. The proposal for pharmaceutical interventio...
Multidisciplinary communication between health professionals allows better control of cardiovascular disease and optimization of pharmacotherapy and health resources, contributing to improving their s...
In Korea, the National Health Insurance Service (NHIS) covers essential healthcare expenses, including cataract surgery. To address concerns that private health insurance (PHI) might have inflated the...
This retrospective, observational study uses nationwide claims data for cataract surgery from 2016 to 2020. We examined trends in utilization and cost, and we estimated the excess numbers of 1) catara...
Between 2016 and 2020, a 36.8% increase occurred in the number of cataract operations, with increases of 63.5% and 731.8% in the total healthcare costs reimbursed by NHIS and PHI, respectively. Over a...
A dramatic increase in the number and cost of cataract operations has occurred over the last 5 years. The PHI-related increase in operations resulted in increased costs to NHIS. Measures to curtail th...
